DM Scan Non-Invasive Diabetes Detection Device

Biomarker-based diagnostic test for early detection and screening of diabetes mellitus. This test supports the company's focus on early identification and intervention in metabolic diseases. The product is part of comprehensive chronic disease screening offerings.

An in vitro detection system for early diagnosis indicators of diabetic nephropathy in human urine. It features multi-channel composite detection with selected indicator combinations including urinary microalbumin, urinary haptoglobin, and urinary creatinine as an internal standard. The system uses dry biochemistry and immunology methods, allows random urine self-testing without invasive procedures, and supports home-based testing with mobile device image upload for server analysis and professional feedback.

In vitro diagnostic system for early detection of diabetic kidney disease through urine analysis. Combines dry-reagent technology with multi-channel detection of key biomarkers including urine microalbumin, uromodulin, and creatinine. Enables both clinical laboratory quantitative analysis and point-of-care home testing with mobile result upload and remote interpretation.

An invention patent product (ZL 2017 1 0507989.9) for in vitro detection of early diagnostic markers of diabetic kidney disease in human urine. It is a Class II urine detection product using dry biochemistry and immunology methods with multi-channel composite detection. The system detects urine microalbumin, urine haptoglobin, and urine creatinine as internal standard. It features non-invasive random urine self-testing, stable dry reagents, and can be used for home self-testing with mobile device result upload for server-based analysis and professional feedback.

A diagnostic test for screening diabetes in at-home and clinical laboratory settings. Supports early detection of this high-prevalence chronic medical condition.

Multi-parameter point-of-care diagnostic device for simultaneous measurement of blood pressure, blood glucose, uric acid, and blood ketone levels. Designed for use in clinical settings, chronic disease management programs, and institutional health monitoring. Utilizes electrochemical and immunofluorescence detection technologies for rapid, integrated metabolic and cardiovascular assessment.

Portable diagnostic instrument incorporating magneto-electrochemical detection for rapid clinical testing. Provides results at the point of patient care with minimal sample preparation requirements.

A point-of-care testing meter for simultaneous measurement of blood glucose and ketone levels. Designed for diabetes management and metabolic monitoring in clinical and home settings. Features precision electrochemical detection with rapid results and user-friendly operation.

An affordable diagnostic instrument designed to deliver rapid and precise diagnostic results compared to conventional methods. The system enables improved health screening and early disease detection at reduced cost.

A diagnostic device for monitoring and assessment related to diabetes care in clinical settings. This product supports patient evaluation and management.

Non-invasive electrical conductivity measurement device for early diabetes risk assessment and complication evaluation. Assesses autonomic nervous system balance through distal nerve endings evaluation. Suitable for preventive screening programs.